# Trial to Evaluate PRO 2000/5 Gels for the Prevention of Vaginally Acquired HIV Infection

> **NCT00262106** · PHASE3 · COMPLETED · sponsor: **Endo Pharmaceuticals** · enrollment: 9404 (actual)

## Conditions studied

- HIV Infections
- Gonorrhea
- Chlamydial Infections
- Genital Herpes

## Interventions

- **DRUG:** PRO 2000/5
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00262106
- **Lead sponsor:** Endo Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-10
- **Primary completion:** 2008-08
- **Final completion:** 2009-09
- **Target enrollment:** 9404 (ACTUAL)
- **Last updated:** 2012-09-10

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00262106

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00262106, "Trial to Evaluate PRO 2000/5 Gels for the Prevention of Vaginally Acquired HIV Infection". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT00262106. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*